| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | axon guidance receptor activity | 9.56e-05 | 13 | 142 | 3 | GO:0008046 | |
| GeneOntologyBiologicalProcess | neuron projection development | BOC EVL HSPG2 CLSTN3 MYO5B CAMK2G SPIRE1 STMND1 ARHGAP35 DCC KATNA1 NCDN AMIGO1 MAPK8IP3 GRIP1 HMCN2 CLIC5 NRXN1 MICALL2 SCN1B DOCK7 LRP2 ROBO2 IL2 PALLD MYO16 PLXNA2 OTOG NCKAP1L | 1.93e-08 | 1285 | 145 | 29 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis | BOC EVL HSPG2 CLSTN3 MYO5B BCL6 ARHGAP35 DCC AP3B1 AMIGO1 MAPK8IP3 GRIP1 HMCN2 CLIC5 F11R NRXN1 ARHGEF7 SCN1B DOCK7 PKHD1 LRP2 ROBO2 PALLD FMNL1 MYO16 PLXNA2 NCKAP1L | 6.23e-08 | 1194 | 145 | 27 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron development | BOC EVL HSPG2 CLSTN3 MYO5B CAMK2G SPIRE1 STMND1 ARHGAP35 DCC KATNA1 NCDN AMIGO1 MAPK8IP3 GRIP1 HMCN2 CLIC5 NRXN1 MICALL2 SCN1B DOCK7 LRP2 ROBO2 IL2 PALLD MYO16 PLXNA2 AGTPBP1 OTOG NCKAP1L | 8.86e-08 | 1463 | 145 | 30 | GO:0048666 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | BOC EVL HSPG2 CLSTN3 MYO5B ARHGAP35 DCC AMIGO1 MAPK8IP3 GRIP1 HMCN2 NRXN1 ARHGEF7 SCN1B DOCK7 LRP2 ROBO2 PALLD MYO16 PLXNA2 NCKAP1L | 2.92e-07 | 819 | 145 | 21 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | BOC EVL HSPG2 CLSTN3 MYO5B ARHGAP35 DCC AMIGO1 MAPK8IP3 GRIP1 HMCN2 NRXN1 ARHGEF7 SCN1B DOCK7 LRP2 ROBO2 PALLD MYO16 PLXNA2 NCKAP1L | 3.35e-07 | 826 | 145 | 21 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | BOC CLSTN3 DSG2 DSG3 PCDHGB1 BCL6 DCC AP3B1 SVEP1 AMIGO1 STK10 HMCN2 F11R HMCN1 NRXN1 VNN1 PKHD1 ROBO2 TLN2 CTLA4 NKAP IL2 PALLD NCKAP1L | 4.90e-07 | 1077 | 145 | 24 | GO:0098609 |
| GeneOntologyBiologicalProcess | axon guidance | BOC EVL HSPG2 ARHGAP35 DCC MAPK8IP3 HMCN2 NRXN1 SCN1B LRP2 ROBO2 PALLD | 8.49e-07 | 285 | 145 | 12 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | BOC EVL HSPG2 ARHGAP35 DCC MAPK8IP3 HMCN2 NRXN1 SCN1B LRP2 ROBO2 PALLD | 8.81e-07 | 286 | 145 | 12 | GO:0097485 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | BOC EVL HSPG2 CLSTN3 MYO5B ARHGAP35 DCC AMIGO1 MAPK8IP3 GRIP1 HMCN2 NRXN1 SCN1B DOCK7 LRP2 ROBO2 PALLD MYO16 PLXNA2 NCKAP1L | 8.88e-07 | 802 | 145 | 20 | GO:0048812 |
| GeneOntologyBiologicalProcess | axonogenesis | BOC EVL HSPG2 MYO5B ARHGAP35 DCC AMIGO1 MAPK8IP3 HMCN2 NRXN1 SCN1B DOCK7 LRP2 ROBO2 PALLD PLXNA2 | 2.47e-06 | 566 | 145 | 16 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | BOC EVL HSPG2 MYO5B ARHGAP35 DCC AMIGO1 MAPK8IP3 GRIP1 HMCN2 CLIC5 NRXN1 SCN1B DOCK7 LRP2 ROBO2 PALLD PLXNA2 | 5.37e-06 | 748 | 145 | 18 | GO:0048667 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 7.17e-06 | 187 | 145 | 9 | GO:0007156 | |
| GeneOntologyBiologicalProcess | axon development | BOC EVL HSPG2 MYO5B ARHGAP35 DCC AMIGO1 MAPK8IP3 HMCN2 NRXN1 SCN1B DOCK7 LRP2 ROBO2 PALLD PLXNA2 | 1.21e-05 | 642 | 145 | 16 | GO:0061564 |
| GeneOntologyBiologicalProcess | positive regulation of cell development | MYO5B INPP5D BCL6 AP3B1 AMIGO1 GRIP1 LIG4 F11R VNN1 LRP2 ROBO2 NKAP IL2 PLXNA2 NCKAP1L | 2.89e-05 | 614 | 145 | 15 | GO:0010720 |
| GeneOntologyBiologicalProcess | cell junction organization | UNC13B CLSTN3 MYO5B DSG2 SVEP1 AMIGO1 KY HMCN2 SHANK2 F11R NRXN1 MICALL2 ARHGEF7 ABCC8 DOCK7 PKHD1 ROBO2 TLN2 PALLD | 5.39e-05 | 974 | 145 | 19 | GO:0034330 |
| GeneOntologyBiologicalProcess | actin filament-based process | EVL THSD7A MYO5B DSG2 SPIRE1 BCL6 ARHGAP35 F11R HMCN1 MICALL2 ARHGEF7 KCNJ3 SCN1B SCN2A TLN2 PALLD FMNL1 NCKAP1L | 7.42e-05 | 912 | 145 | 18 | GO:0030029 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CLSTN3 DSG2 DSG3 PCDHGB1 AMIGO1 HMCN2 HMCN1 NRXN1 ROBO2 PALLD | 7.60e-05 | 313 | 145 | 10 | GO:0098742 |
| GeneOntologyBiologicalProcess | regulation of cell development | RARG MYO5B INPP5D BCL6 DCC AP3B1 AMIGO1 GRIP1 LIG4 F11R VNN1 ABCC8 DOCK7 LRP2 ROBO2 CTLA4 NKAP IL2 PLXNA2 NCKAP1L | 8.39e-05 | 1095 | 145 | 20 | GO:0060284 |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | BOC FNDC3B MYO5B INPP5D VSTM2A BCL6 AP3B1 AMIGO1 MAPK8IP3 GRIP1 LIG4 F11R ADAMTS9 VNN1 LRP2 ROBO2 NKAP IL2 PLXNA2 NCKAP1L | 1.46e-04 | 1141 | 145 | 20 | GO:0045597 |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 1.51e-04 | 162 | 145 | 7 | GO:0045621 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | UNC13B EVL CLSTN3 MYO5B SPIRE1 ARHGAP35 DCC AMIGO1 GRIP1 LIG4 MELTF NRXN1 ARHGEF7 ABCC8 SCN1B LRP2 ROBO2 PLD6 DNM1 PLXNA2 NCKAP1L RAB11FIP3 | 2.23e-04 | 1366 | 145 | 22 | GO:0051130 |
| GeneOntologyBiologicalProcess | regulation of B cell proliferation | 2.52e-04 | 80 | 145 | 5 | GO:0030888 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to plasma membrane | 2.92e-04 | 128 | 145 | 6 | GO:1903076 | |
| GeneOntologyBiologicalProcess | regulation of B cell differentiation | 3.04e-04 | 46 | 145 | 4 | GO:0045577 | |
| GeneOntologyCellularComponent | axon | UNC13B BOC CAD PCDHGB1 DCC KATNA1 AP3B1 NCDN AMIGO1 MAPK8IP3 GRIP1 HMCN2 SHANK2 NRXN1 ARHGEF7 SCN1B SCN2A PRKAA2 DOCK7 LRP2 NAV1 ROBO2 WDFY3 DNM1 PALLD AGTPBP1 | 4.67e-10 | 891 | 145 | 26 | GO:0030424 |
| GeneOntologyCellularComponent | growth cone | BOC PCDHGB1 DCC KATNA1 MAPK8IP3 SHANK2 NRXN1 ARHGEF7 DOCK7 LRP2 PALLD | 1.17e-06 | 245 | 145 | 11 | GO:0030426 |
| GeneOntologyCellularComponent | site of polarized growth | BOC PCDHGB1 DCC KATNA1 MAPK8IP3 SHANK2 NRXN1 ARHGEF7 DOCK7 LRP2 PALLD | 1.59e-06 | 253 | 145 | 11 | GO:0030427 |
| GeneOntologyCellularComponent | distal axon | UNC13B BOC CAD PCDHGB1 DCC KATNA1 MAPK8IP3 GRIP1 SHANK2 NRXN1 ARHGEF7 DOCK7 LRP2 PALLD | 2.12e-06 | 435 | 145 | 14 | GO:0150034 |
| GeneOntologyCellularComponent | axonal growth cone | 1.46e-05 | 45 | 145 | 5 | GO:0044295 | |
| GeneOntologyCellularComponent | main axon | 3.63e-05 | 89 | 145 | 6 | GO:0044304 | |
| GeneOntologyCellularComponent | cell cortex | UNC13B MYO5B INPP5D SPIRE1 CYTIP GRIP1 HMCN2 CLIC5 HMCN1 ARHGEF7 FMNL1 | 5.76e-05 | 371 | 145 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | postsynaptic recycling endosome membrane | 7.04e-04 | 6 | 145 | 2 | GO:0098944 | |
| GeneOntologyCellularComponent | neuronal cell body | BOC CAD MYO5B KATNA1 NCDN AMIGO1 GRIP1 HMCN2 SHANK2 NRXN1 ARHGEF7 SCN1B PRKAA2 WDFY3 PALLD | 7.07e-04 | 835 | 145 | 15 | GO:0043025 |
| GeneOntologyCellularComponent | cell body | BOC CAD MYO5B KATNA1 NCDN AMIGO1 MAPK8IP3 GRIP1 HMCN2 SHANK2 NRXN1 ARHGEF7 SCN1B PRKAA2 WDFY3 PALLD | 7.36e-04 | 929 | 145 | 16 | GO:0044297 |
| GeneOntologyCellularComponent | cleavage furrow | 8.53e-04 | 61 | 145 | 4 | GO:0032154 | |
| GeneOntologyCellularComponent | intercalated disc | 1.28e-03 | 68 | 145 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | endocytic vesicle | 1.47e-03 | 384 | 145 | 9 | GO:0030139 | |
| GeneOntologyCellularComponent | extracellular matrix | COL5A2 HSPG2 FRAS1 ITLN1 F13A1 SVEP1 HMCN2 HMCN1 LRIG1 ADAMTS9 PLXNA2 OTOG | 2.10e-03 | 656 | 145 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | somatodendritic compartment | BOC CLSTN3 CAD MYO5B KATNA1 NCDN AMIGO1 MAPK8IP3 GRIP1 HMCN2 SHANK2 NRXN1 ARHGEF7 SCN1B PRKAA2 LRP2 WDFY3 PALLD | 2.14e-03 | 1228 | 145 | 18 | GO:0036477 |
| GeneOntologyCellularComponent | external encapsulating structure | COL5A2 HSPG2 FRAS1 ITLN1 F13A1 SVEP1 HMCN2 HMCN1 LRIG1 ADAMTS9 PLXNA2 OTOG | 2.15e-03 | 658 | 145 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | T-tubule | 2.23e-03 | 79 | 145 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | cell division site | 2.34e-03 | 80 | 145 | 4 | GO:0032153 | |
| GeneOntologyCellularComponent | filtration diaphragm | 2.52e-03 | 11 | 145 | 2 | GO:0036056 | |
| GeneOntologyCellularComponent | slit diaphragm | 2.52e-03 | 11 | 145 | 2 | GO:0036057 | |
| GeneOntologyCellularComponent | postsynaptic endosome membrane | 2.52e-03 | 11 | 145 | 2 | GO:0098895 | |
| MousePheno | abnormal respiratory system physiology | NPC1 COL5A2 HSPG2 FRAS1 DSG3 INPP5D BCL6 DCC AP3B1 F13A1 MAPK8IP3 JARID2 KY NRXN1 KCNJ3 SCN2A PKHD1 LRP2 CTLA4 CABIN1 IL2 NCKAP1L | 4.44e-06 | 897 | 117 | 22 | MP:0002133 |
| MousePheno | heart inflammation | 1.73e-05 | 39 | 117 | 5 | MP:0001853 | |
| MousePheno | increased effector memory CD4-positive, alpha-beta T cell number | 2.22e-05 | 41 | 117 | 5 | MP:0010844 | |
| MousePheno | abnormal effector memory CD4-positive, alpha-beta T cell number | 4.84e-05 | 48 | 117 | 5 | MP:0012770 | |
| MousePheno | abnormal effector memory CD4-positive, alpha-beta T cell morphology | 4.84e-05 | 48 | 117 | 5 | MP:0010843 | |
| MousePheno | abnormal CD4-positive, alpha-beta memory T cell morphology | 9.39e-05 | 55 | 117 | 5 | MP:0010834 | |
| MousePheno | kidney cyst | 1.19e-04 | 177 | 117 | 8 | MP:0003675 | |
| MousePheno | increased CD4-positive, alpha-beta memory T cell number | 1.32e-04 | 59 | 117 | 5 | MP:0010835 | |
| Domain | Ig-like_fold | BOC FNDC3B HSPG2 VSTM2A DCC F13A1 AMIGO1 IFNGR2 FNDC7 HMCN2 SHANK2 F11R HMCN1 LRIG1 SCN1B PKHD1 ROBO2 CD300LG CTLA4 LY9 PALLD GPA33 PLXNA2 | 1.52e-09 | 706 | 136 | 23 | IPR013783 |
| Domain | - | BOC FNDC3B HSPG2 VSTM2A DCC F13A1 AMIGO1 IFNGR2 FNDC7 F11R HMCN1 LRIG1 SCN1B PKHD1 ROBO2 CD300LG CTLA4 LY9 PALLD GPA33 PLXNA2 | 1.39e-08 | 663 | 136 | 21 | 2.60.40.10 |
| Domain | Ig_V-set | BOC HSPG2 VSTM2A AMIGO1 F11R HMCN1 SCN1B ROBO2 CD300LG CTLA4 GPA33 | 2.33e-07 | 199 | 136 | 11 | IPR013106 |
| Domain | IG | BOC HSPG2 VSTM2A DCC AMIGO1 HMCN2 F11R HMCN1 LRIG1 ROBO2 CD300LG CTLA4 LY9 PALLD GPA33 | 4.43e-07 | 421 | 136 | 15 | SM00409 |
| Domain | Ig_sub | BOC HSPG2 VSTM2A DCC AMIGO1 HMCN2 F11R HMCN1 LRIG1 ROBO2 CD300LG CTLA4 LY9 PALLD GPA33 | 4.43e-07 | 421 | 136 | 15 | IPR003599 |
| Domain | IG_LIKE | BOC HSPG2 VSTM2A DCC AMIGO1 HMCN2 F11R HMCN1 LRIG1 SCN1B ROBO2 CD300LG CTLA4 LY9 PALLD GPA33 | 5.87e-07 | 491 | 136 | 16 | PS50835 |
| Domain | Ig-like_dom | BOC HSPG2 VSTM2A DCC AMIGO1 HMCN2 F11R HMCN1 LRIG1 SCN1B ROBO2 CD300LG CTLA4 LY9 PALLD GPA33 | 8.08e-07 | 503 | 136 | 16 | IPR007110 |
| Domain | Ig_I-set | 1.31e-06 | 190 | 136 | 10 | IPR013098 | |
| Domain | I-set | 1.31e-06 | 190 | 136 | 10 | PF07679 | |
| Domain | V-set | 8.22e-06 | 184 | 136 | 9 | PF07686 | |
| Domain | IGc2 | 8.75e-06 | 235 | 136 | 10 | SM00408 | |
| Domain | Ig_sub2 | 8.75e-06 | 235 | 136 | 10 | IPR003598 | |
| Domain | IGv | 1.78e-05 | 75 | 136 | 6 | SM00406 | |
| Domain | - | 6.82e-05 | 95 | 136 | 6 | 2.60.120.200 | |
| Domain | EGF-like_dom | 8.86e-05 | 249 | 136 | 9 | IPR000742 | |
| Domain | Neural_cell_adh | 3.13e-04 | 4 | 136 | 2 | IPR009138 | |
| Domain | G2F | 3.13e-04 | 4 | 136 | 2 | PF07474 | |
| Domain | Desmoglein | 3.13e-04 | 4 | 136 | 2 | IPR009123 | |
| Domain | NIDOGEN_G2 | 3.13e-04 | 4 | 136 | 2 | PS50993 | |
| Domain | GFP | 3.13e-04 | 4 | 136 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 3.13e-04 | 4 | 136 | 2 | IPR006605 | |
| Domain | EGF_3 | 3.30e-04 | 235 | 136 | 8 | PS50026 | |
| Domain | ig | 4.88e-04 | 190 | 136 | 7 | PF00047 | |
| Domain | Immunoglobulin | 4.88e-04 | 190 | 136 | 7 | IPR013151 | |
| Domain | ASX_HYDROXYL | 8.23e-04 | 100 | 136 | 5 | PS00010 | |
| Domain | Growth_fac_rcpt_ | 9.93e-04 | 156 | 136 | 6 | IPR009030 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.07e-03 | 106 | 136 | 5 | IPR000152 | |
| Domain | Pept_M16_Zn_BS | 1.08e-03 | 7 | 136 | 2 | IPR001431 | |
| Domain | Pept_M16_dom | 1.08e-03 | 7 | 136 | 2 | IPR011237 | |
| Domain | Metalloenz_LuxS/M16 | 1.08e-03 | 7 | 136 | 2 | IPR011249 | |
| Domain | Desmosomal_cadherin | 1.08e-03 | 7 | 136 | 2 | IPR009122 | |
| Domain | Peptidase_M16 | 1.08e-03 | 7 | 136 | 2 | PF00675 | |
| Domain | Peptidase_M16_C | 1.08e-03 | 7 | 136 | 2 | IPR007863 | |
| Domain | Peptidase_M16_C | 1.08e-03 | 7 | 136 | 2 | PF05193 | |
| Domain | Pept_M16_N | 1.08e-03 | 7 | 136 | 2 | IPR011765 | |
| Domain | - | 1.08e-03 | 7 | 136 | 2 | 3.30.830.10 | |
| Domain | INSULINASE | 1.08e-03 | 7 | 136 | 2 | PS00143 | |
| Domain | fn3 | 1.21e-03 | 162 | 136 | 6 | PF00041 | |
| Domain | EGF | 1.69e-03 | 235 | 136 | 7 | SM00181 | |
| Pubmed | 3.28e-08 | 162 | 147 | 9 | 25826454 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NPC1 UNC13B HSPG2 SYNRG FRAS1 HIVEP2 RARG TRMT1 SPIRE1 ARHGAP35 MAPK8IP3 STK10 GET4 SHANK2 NAV1 TLN2 PCNX1 WDFY3 CABIN1 RAB11FIP3 | 4.80e-08 | 1105 | 147 | 20 | 35748872 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | UNC13B ZFC3H1 KATNA1 STK31 PCF11 SAFB HMCN2 TLN2 NKAP PALLD FMNL1 | 4.35e-07 | 361 | 147 | 11 | 26167880 |
| Pubmed | EVL FAM120B CAD MYO5B CAMK2G SPIRE1 ARHGAP35 AP3B1 NCDN MAPK8IP3 GRAMD1B SAFB SHANK2 LRIG1 SCN2A DOCK7 NAV1 TLN2 UQCRC2 DNM1 AGTPBP1 | 6.95e-07 | 1431 | 147 | 21 | 37142655 | |
| Pubmed | EVL RARG MYO5B PCDHGB1 TTC16 CAMK2G ZFC3H1 DCC H3-4 STK31 KRT73 PCF11 LIG4 SAFB SHANK2 NRXN1 PMPCA PKHD1 UQCRC2 PLXNA2 | 3.09e-06 | 1442 | 147 | 20 | 35575683 | |
| Pubmed | EVL SYNRG CAD CAMK2G ARHGAP35 MAPK8IP3 GRAMD1B SAFB SHANK2 NRXN1 ARHGEF7 KCNJ3 GLYR1 DOCK7 NAV1 TLN2 UQCRC2 | 7.01e-06 | 1139 | 147 | 17 | 36417873 | |
| Pubmed | 7.52e-06 | 167 | 147 | 7 | 22159717 | ||
| Pubmed | UNC13B FRAS1 CLSTN3 PHF24 NCDN GRAMD1B DOCK7 NAV1 PLXNA2 AGTPBP1 | 9.87e-06 | 407 | 147 | 10 | 12693553 | |
| Pubmed | Paracrine IL-2 Is Required for Optimal Type 2 Effector Cytokine Production. | 1.77e-05 | 2 | 147 | 2 | 28468971 | |
| Pubmed | Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity. | 1.77e-05 | 2 | 147 | 2 | 34665220 | |
| Pubmed | Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma. | 1.77e-05 | 2 | 147 | 2 | 26469831 | |
| Pubmed | Transgenic expression of CTLA-4 controls lymphoproliferation in IL-2-deficient mice. | 1.77e-05 | 2 | 147 | 2 | 15494488 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 25626682 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 20923451 | ||
| Pubmed | Desmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion. | 1.77e-05 | 2 | 147 | 2 | 23326495 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24782306 | ||
| Pubmed | Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues. | 1.77e-05 | 2 | 147 | 2 | 32035013 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 18155042 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 33193387 | ||
| Pubmed | Perlecan: a major IL-2-binding proteoglycan in murine spleen. | 1.77e-05 | 2 | 147 | 2 | 18040286 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24094106 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 25251699 | ||
| Pubmed | 1.99e-05 | 130 | 147 | 6 | 12421765 | ||
| Pubmed | 2.17e-05 | 132 | 147 | 6 | 26439863 | ||
| Pubmed | FNDC3B FRAS1 AP3B1 NCDN DENND3 LIG4 ARHGEF7 ASB3 DOCK7 UQCRC2 DNM1 PALLD | 2.22e-05 | 650 | 147 | 12 | 38777146 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.10e-05 | 208 | 147 | 7 | 33230847 | |
| Pubmed | A locus for renal malformations including vesico-ureteric reflux on chromosome 13q33-34. | 3.24e-05 | 15 | 147 | 3 | 16565260 | |
| Pubmed | Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. | 3.42e-05 | 143 | 147 | 6 | 30397336 | |
| Pubmed | 3.52e-05 | 87 | 147 | 5 | 12465718 | ||
| Pubmed | 3.98e-05 | 16 | 147 | 3 | 16880404 | ||
| Pubmed | THSD7A CMTR1 MYO5B ZFC3H1 ARHGAP35 DENND3 AMIGO1 PCF11 ADAMTS9 PALLD | 5.03e-05 | 493 | 147 | 10 | 15368895 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 12388743 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 18021981 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 32661924 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 12787134 | ||
| Pubmed | A secreted protein promotes cleavage furrow maturation during cytokinesis. | 5.31e-05 | 3 | 147 | 2 | 21215633 | |
| Pubmed | Regulatory T cells impede acute and long-term immunity to blood-stage malaria through CTLA-4. | 5.31e-05 | 3 | 147 | 2 | 28892065 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 19270815 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 16052353 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 24550509 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 17015624 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 8143788 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 25771912 | ||
| Pubmed | BetaPix up-regulates Na+/H+ exchanger 3 through a Shank2-mediated protein-protein interaction. | 5.31e-05 | 3 | 147 | 2 | 20080968 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 25237006 | ||
| Pubmed | Expression of desmogleins 1-3 and their clinical impacts on human lung cancer. | 5.31e-05 | 3 | 147 | 2 | 25468811 | |
| Pubmed | CAD CAMK2G NCDN MAPK8IP3 CNTNAP5 SHANK2 NRXN1 ARHGEF7 DOCK7 NAV1 TLN2 WDFY3 DNM1 CABIN1 | 6.26e-05 | 963 | 147 | 14 | 28671696 | |
| Pubmed | 1.01e-04 | 251 | 147 | 7 | 27507650 | ||
| Pubmed | 1.05e-04 | 175 | 147 | 6 | 28071719 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 23690575 | ||
| Pubmed | Confirmation of STAT4, IL2/IL21, and CTLA4 polymorphisms in rheumatoid arthritis. | 1.06e-04 | 4 | 147 | 2 | 19404967 | |
| Pubmed | The Nef protein of HIV-1 associates with rafts and primes T cells for activation. | 1.06e-04 | 4 | 147 | 2 | 10618429 | |
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 12787123 | ||
| Pubmed | The calcineurin-binding protein cain is a negative regulator of synaptic vesicle endocytosis. | 1.06e-04 | 4 | 147 | 2 | 10931822 | |
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 26221972 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 12705872 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 35801810 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 10639163 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 22406686 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 36007682 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 23974956 | ||
| Pubmed | AMPKα2 exerts its anti-inflammatory effects through PARP-1 and Bcl-6. | 1.06e-04 | 4 | 147 | 2 | 23382195 | |
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 12626503 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 22189787 | ||
| Pubmed | 1.06e-04 | 4 | 147 | 2 | 34504132 | ||
| Pubmed | NPC1 UNC13B CLSTN3 HIVEP2 DNAAF9 ZFC3H1 MAPK8IP3 ADAMTS9 ASB3 AHCY LRP2 TLN2 WDFY3 DNM1 CABIN1 AGTPBP1 | 1.14e-04 | 1285 | 147 | 16 | 35914814 | |
| Pubmed | Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. | 1.41e-04 | 62 | 147 | 4 | 17975119 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | EVL MYO5B CAMK2G MAPK8IP3 CYTIP GRIP1 ARHGEF7 SUPT4H1 GLYR1 AHCY | 1.43e-04 | 560 | 147 | 10 | 21653829 |
| Pubmed | Gene variants associated with ischemic stroke: the cardiovascular health study. | 1.50e-04 | 63 | 147 | 4 | 19023099 | |
| Pubmed | 1.60e-04 | 64 | 147 | 4 | 22261194 | ||
| Pubmed | IDD3 and IDD5 alleles from nod mice mediate Sjögren's syndrome-like autoimmunity. | 1.76e-04 | 5 | 147 | 2 | 12614028 | |
| Pubmed | Netrin1-DCC-Mediated Attraction Guides Post-Crossing Commissural Axons in the Hindbrain. | 1.76e-04 | 5 | 147 | 2 | 26290247 | |
| Pubmed | 1.76e-04 | 5 | 147 | 2 | 16443792 | ||
| Pubmed | Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. | 1.76e-04 | 5 | 147 | 2 | 16885196 | |
| Pubmed | 1.76e-04 | 5 | 147 | 2 | 24337656 | ||
| Pubmed | 1.76e-04 | 5 | 147 | 2 | 29662170 | ||
| Pubmed | Mesenchymal dysplasia: a recessive mutation on chromosome 13 of the mouse. | 1.76e-04 | 5 | 147 | 2 | 8830098 | |
| Pubmed | Strain-specific copy number variation in the intelectin locus on the 129 mouse chromosome 1. | 1.76e-04 | 5 | 147 | 2 | 21324158 | |
| Pubmed | The cytoplasmic tail of fibrocystin contains a ciliary targeting sequence. | 1.76e-04 | 5 | 147 | 2 | 20048263 | |
| Pubmed | Analysis of multiple candidate genes in association with phenotypes of multiple sclerosis. | 1.79e-04 | 26 | 147 | 3 | 20378664 | |
| Pubmed | 2.04e-04 | 126 | 147 | 5 | 16284245 | ||
| Pubmed | NPC1 HK3 SPIRE1 AP3B1 F13A1 NCDN ZNF750 SINHCAF SUPT4H1 KCNJ3 GLYR1 LRP2 NCKAP1L RAB11FIP3 | 2.15e-04 | 1084 | 147 | 14 | 11544199 | |
| Pubmed | 2.24e-04 | 28 | 147 | 3 | 32801337 | ||
| Pubmed | 2.28e-04 | 202 | 147 | 6 | 24639526 | ||
| Pubmed | 2.49e-04 | 29 | 147 | 3 | 22613833 | ||
| Pubmed | Fine mapping of Dyscalc1, the major genetic determinant of dystrophic cardiac calcification in mice. | 2.63e-04 | 6 | 147 | 2 | 16705021 | |
| Pubmed | Association of the AFF3 gene and IL2/IL21 gene region with juvenile idiopathic arthritis. | 2.63e-04 | 6 | 147 | 2 | 20072139 | |
| Pubmed | 2.63e-04 | 6 | 147 | 2 | 24700879 | ||
| Pubmed | Craniofacial consequences of connective tissue disorders in mice. | 2.63e-04 | 6 | 147 | 2 | 6391574 | |
| Pubmed | Global mapping of Salmonella enterica-host protein-protein interactions during infection. | 2.63e-04 | 6 | 147 | 2 | 34237247 | |
| Pubmed | 2.63e-04 | 6 | 147 | 2 | 17462874 | ||
| Pubmed | 2.63e-04 | 6 | 147 | 2 | 24909888 | ||
| Pubmed | Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop. | 2.63e-04 | 6 | 147 | 2 | 34157302 | |
| Pubmed | 2.63e-04 | 6 | 147 | 2 | 9404003 | ||
| Pubmed | 2.63e-04 | 6 | 147 | 2 | 25673849 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | FNDC3B SYNRG CMTR1 CAMK2G ZFC3H1 ARHGAP35 AP3B1 DOCK7 UQCRC2 PALLD AGTPBP1 | 2.70e-04 | 724 | 147 | 11 | 36232890 |
| Pubmed | 3.10e-04 | 76 | 147 | 4 | 10574461 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG HIVEP2 DSG2 SPIRE1 GRIP1 SUPT4H1 PRKAA2 DOCK7 NAV1 PLEKHM3 PALLD OTOG | 3.12e-04 | 861 | 147 | 12 | 36931259 |
| Pubmed | Arf4 is required for Mammalian development but dispensable for ciliary assembly. | 3.67e-04 | 7 | 147 | 2 | 24586199 | |
| Pubmed | A tug of war between DCC and ROBO1 signaling during commissural axon guidance. | 3.67e-04 | 7 | 147 | 2 | 37149867 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.93e-06 | 161 | 94 | 8 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 7.41e-06 | 193 | 94 | 8 | 594 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.26e-05 | 163 | 94 | 7 | 590 | |
| GeneFamily | Fibronectin type III domain containing | 1.87e-04 | 160 | 94 | 6 | 555 | |
| GeneFamily | Desmosomal cadherins | 5.52e-04 | 7 | 94 | 2 | 1188 | |
| GeneFamily | Fibulins | 7.34e-04 | 8 | 94 | 2 | 556 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | THSD7A VSTM2A DCC NCDN GRIP1 SHANK2 F11R NRXN1 SCN2A NAV1 ROBO2 PLXNA2 | 1.06e-05 | 465 | 144 | 12 | M39066 |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | RAMP3 PHF24 NCDN SHANK2 NRXN1 SCN2A PRKAA2 NAV1 DNM1 MYO16 MPPED1 AGTPBP1 | 1.71e-05 | 488 | 144 | 12 | M39104 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | UNC13B FRAS1 ZFC3H1 DCC GRAMD1B SHANK2 LRP2 ROBO2 TLN2 DNM1 RAB11FIP3 | 2.04e-05 | 417 | 144 | 11 | M39224 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | BOC EVL MYO5B DSG2 ABHD3 SVEP1 PCF11 IFNGR2 CNTNAP5 F11R HMCN1 VNN1 MRC2 AHCY ROBO2 RASL11B DNM1 PALLD PLXNA2 | 4.14e-06 | 858 | 141 | 19 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRAS1 DCC MELTF HMCN1 NRXN1 SCN2A PKHD1 LRP2 TLN2 MYO16 OTOG | 2.89e-11 | 184 | 147 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRAS1 DCC MELTF HMCN1 NRXN1 SCN2A PKHD1 LRP2 TLN2 MYO16 OTOG | 2.89e-11 | 184 | 147 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FRAS1 DCC MELTF HMCN1 NRXN1 SCN2A PKHD1 LRP2 TLN2 MYO16 OTOG | 2.89e-11 | 184 | 147 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | FNDC3B EVL COL5A2 CLSTN3 BCL6 SVEP1 MICALL2 ABCA6 MRC2 PALLD MYO16 | 6.72e-11 | 199 | 147 | 11 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | LA|World / Chamber and Cluster_Paper | 9.53e-10 | 193 | 147 | 10 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.28e-08 | 187 | 147 | 9 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.61e-08 | 192 | 147 | 9 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | FRAS1 MYO5B GRIP1 GRAMD1B SHANK2 PRKAA2 PKHD1 LRP2 RAB11FIP3 | 1.69e-08 | 193 | 147 | 9 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-08 | 193 | 147 | 9 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-08 | 194 | 147 | 9 | 4d6c9b016e3a0641954a8ea10c97d1cd76fadd9f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-08 | 194 | 147 | 9 | be869e186386d03ebb670971dd24fa656b4b0edf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-08 | 194 | 147 | 9 | 633fe72cc8a489abde12428e326478409ca03263 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-08 | 194 | 147 | 9 | 87a86df0b542f287b0b20f4a4b1a37002271671d | |
| ToppCell | Adult-Immune-monocyte|Adult / Lineage, Cell type, age group and donor | 1.93e-08 | 196 | 147 | 9 | 3ef193c5180de3137daf886492e74fc574bc9767 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.93e-08 | 196 | 147 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-leukocyte-proliferating_myeloid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.44e-08 | 153 | 147 | 8 | 596bb7cfd1c713708ce73df30d890a0233eae7f7 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-leukocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.44e-08 | 153 | 147 | 8 | 8cc2667213bfac37545bb63181e88ef1f1834413 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-08 | 160 | 147 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-08 | 160 | 147 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-07 | 177 | 147 | 8 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-07 | 179 | 147 | 8 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-07 | 181 | 147 | 8 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.70e-07 | 182 | 147 | 8 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-07 | 182 | 147 | 8 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_T-T_NK-CD8_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-07 | 183 | 147 | 8 | bbe389d5bee8754210f5ec4039a5ecba6a3977a9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-07 | 185 | 147 | 8 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.00e-07 | 186 | 147 | 8 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.09e-07 | 187 | 147 | 8 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.09e-07 | 187 | 147 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.17e-07 | 188 | 147 | 8 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.17e-07 | 188 | 147 | 8 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-07 | 190 | 147 | 8 | b772a5d281fe016f259ddda80d6f33d949dcac2b | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.36e-07 | 190 | 147 | 8 | d2afa08ad868acc6fce308ec21b0bf93591d4010 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-07 | 191 | 147 | 8 | 96a7179a845d3daa046ed71fa45c51255f130a7f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-07 | 191 | 147 | 8 | 1a2d5fec2bea96da2154b0aed252f1bb35102f6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-07 | 191 | 147 | 8 | 326b4541069efedc8ab409f85bb11f77346dda90 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-07 | 192 | 147 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-07 | 192 | 147 | 8 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.55e-07 | 192 | 147 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-07 | 193 | 147 | 8 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-07 | 193 | 147 | 8 | 12f1333f11e6c262954ad7912d8fd2962ab06d25 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-07 | 193 | 147 | 8 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.66e-07 | 193 | 147 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-07 | 194 | 147 | 8 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.76e-07 | 194 | 147 | 8 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-07 | 194 | 147 | 8 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-07 | 195 | 147 | 8 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-07 | 195 | 147 | 8 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.10e-07 | 197 | 147 | 8 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 3.10e-07 | 197 | 147 | 8 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | COVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type | 3.10e-07 | 197 | 147 | 8 | 9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.23e-07 | 198 | 147 | 8 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.23e-07 | 198 | 147 | 8 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.23e-07 | 198 | 147 | 8 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 3.23e-07 | 198 | 147 | 8 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.35e-07 | 199 | 147 | 8 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.35e-07 | 199 | 147 | 8 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.35e-07 | 199 | 147 | 8 | bc93e5c36ab60b66fb633c954b05d4dc09a7f152 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 3.35e-07 | 199 | 147 | 8 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 200 | 147 | 8 | d8459e45a8396a9ee063666a1928c649162c5727 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.48e-07 | 200 | 147 | 8 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.48e-07 | 200 | 147 | 8 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.48e-07 | 200 | 147 | 8 | b7ab3f644e6002635771dccaa192a111b4e0ed5b | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.48e-07 | 200 | 147 | 8 | 2e01a35caeff5967a8b873c5122500d068dcf54c | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 200 | 147 | 8 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.48e-07 | 200 | 147 | 8 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 200 | 147 | 8 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 200 | 147 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.48e-07 | 200 | 147 | 8 | 881ab995c90d75fd987d6e8f1f926a4bfcc4235f | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 200 | 147 | 8 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 200 | 147 | 8 | b4277b6faa69f20974696c7c422311f5c89e3663 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-07 | 158 | 147 | 7 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.72e-07 | 158 | 147 | 7 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.41e-06 | 167 | 147 | 7 | 25af48c640e67848594f5902867ba325fc105da4 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 1.85e-06 | 174 | 147 | 7 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 2.00e-06 | 176 | 147 | 7 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.23e-06 | 179 | 147 | 7 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 180 | 147 | 7 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-06 | 180 | 147 | 7 | bb2dbf7ed03d5ac765635b7afe738efa822841d0 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.32e-06 | 180 | 147 | 7 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 180 | 147 | 7 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-06 | 180 | 147 | 7 | c62417f205bcbf3b212ae177f63562ec6467c855 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.41e-06 | 181 | 147 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 2.59e-06 | 183 | 147 | 7 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-06 | 183 | 147 | 7 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-06 | 185 | 147 | 7 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-06 | 185 | 147 | 7 | aa2c36e2cce0f0a536cd1dfc3788b6fee6f21b6b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-06 | 186 | 147 | 7 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.99e-06 | 187 | 147 | 7 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-06 | 187 | 147 | 7 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.99e-06 | 187 | 147 | 7 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-06 | 187 | 147 | 7 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-06 | 188 | 147 | 7 | 58ccb31cdf43167872ef0fc737e6f9c51ee2e060 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.09e-06 | 188 | 147 | 7 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.09e-06 | 188 | 147 | 7 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-06 | 189 | 147 | 7 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.20e-06 | 189 | 147 | 7 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-06 | 189 | 147 | 7 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.20e-06 | 189 | 147 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-06 | 189 | 147 | 7 | 28b502611829e4a24caff2562545c7db97686099 | |
| Disease | Colorectal Carcinoma | UNC13B BOC EVL CLSTN3 CAD HK3 DCC NCDN KRT73 ABCA6 ABCC8 PKHD1 LRP2 UQCRC2 AGTPBP1 | 1.75e-06 | 702 | 143 | 15 | C0009402 |
| Disease | cortical thickness | COL5A2 HSPG2 DNAAF9 ARHGAP35 DENND3 MAPK8IP3 GRIP1 PMPCA ADAMTS9 GLYR1 DOCK7 PKHD1 NAV1 ROBO2 RASL11B MYO16 PLXNA2 | 2.93e-05 | 1113 | 143 | 17 | EFO_0004840 |
| Disease | Cryptophthalmos syndrome | 6.97e-05 | 3 | 143 | 2 | C0265233 | |
| Disease | FRASER SYNDROME 1 | 6.97e-05 | 3 | 143 | 2 | C4551480 | |
| Disease | vital capacity | HSPG2 HIVEP2 RARG CAMK2G DCC AP3B1 STK31 SVEP1 MSRB3 KY MELTF CLIC5 HMCN1 MRC2 LRP2 MYO16 OTOG | 1.06e-04 | 1236 | 143 | 17 | EFO_0004312 |
| Disease | Fraser syndrome (implicated_via_orthology) | 1.39e-04 | 4 | 143 | 2 | DOID:0090001 (implicated_via_orthology) | |
| Disease | hyperinsulinemic hypoglycemia (implicated_via_orthology) | 2.31e-04 | 5 | 143 | 2 | DOID:13317 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | COL5A2 DNAAF9 DENND3 SVEP1 MSRB3 GRIP1 LRIG1 PMPCA ADAMTS9 PKHD1 NAV1 ROBO2 RASL11B TLN2 PLEKHM3 MYO16 PLXNA2 | 2.88e-04 | 1345 | 143 | 17 | EFO_0010736 |
| Disease | clubfoot (implicated_via_orthology) | 3.45e-04 | 6 | 143 | 2 | DOID:11836 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 3.46e-04 | 447 | 143 | 9 | C3714756 | |
| Disease | response to bronchodilator, FEV/FEC ratio | THSD7A DENND3 MSRB3 GRIP1 CNTNAP5 SHANK2 NRXN1 ASB3 PKHD1 ROBO2 PLXNA2 OTOG | 3.68e-04 | 766 | 143 | 12 | EFO_0004713, GO_0097366 |
| Disease | Seizure, Febrile, Simple | 4.82e-04 | 7 | 143 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 4.82e-04 | 7 | 143 | 2 | C0751057 | |
| Disease | longevity | 4.88e-04 | 284 | 143 | 7 | EFO_0004300 | |
| Disease | Profound Mental Retardation | 5.95e-04 | 139 | 143 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 5.95e-04 | 139 | 143 | 5 | C0025363 | |
| Disease | Mental deficiency | 5.95e-04 | 139 | 143 | 5 | C0917816 | |
| Disease | X-linked infantile spasms | 6.41e-04 | 8 | 143 | 2 | C4552072 | |
| Disease | Intestinal Diseases | 6.41e-04 | 8 | 143 | 2 | C0021831 | |
| Disease | hoarding disorder | 7.08e-04 | 36 | 143 | 3 | EFO_0803361 | |
| Disease | neuroimaging measurement | COL5A2 CAMK2G ARHGAP35 DCC DENND3 MAPK8IP3 MSRB3 AHCY PKHD1 ROBO2 RASL11B TLN2 MYO16 PLXNA2 | 7.18e-04 | 1069 | 143 | 14 | EFO_0004346 |
| Disease | alopecia areata (is_implicated_in) | 8.21e-04 | 9 | 143 | 2 | DOID:986 (is_implicated_in) | |
| Disease | Febrile Convulsions | 8.21e-04 | 9 | 143 | 2 | C0009952 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 8.21e-04 | 9 | 143 | 2 | C3502809 | |
| Disease | obsolete_red blood cell distribution width | FNDC3B HCAR1 TRMT1 UBAP1 KBTBD2 DCK AP3B1 STK10 LRIG1 PMPCA ABCA6 ASB3 CD300LG IL2 MYO16 KNL1 | 8.52e-04 | 1347 | 143 | 16 | EFO_0005192 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 8.91e-04 | 152 | 143 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Graves ophthalmopathy (is_implicated_in) | 1.02e-03 | 10 | 143 | 2 | DOID:0081120 (is_implicated_in) | |
| Disease | interstitial lung disease (is_implicated_in) | 1.02e-03 | 10 | 143 | 2 | DOID:3082 (is_implicated_in) | |
| Disease | Schizophrenia | MYO5B DCC JARID2 NRXN1 KCNJ3 LRP2 NAV1 CTLA4 DNM1 IL2 MYO16 PLXNA2 | 1.27e-03 | 883 | 143 | 12 | C0036341 |
| Disease | oropharynx cancer | 1.45e-03 | 46 | 143 | 3 | EFO_1001931 | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 1.49e-03 | 12 | 143 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.49e-03 | 12 | 143 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | diastolic blood pressure, systolic blood pressure | 1.63e-03 | 670 | 143 | 10 | EFO_0006335, EFO_0006336 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 1.74e-03 | 49 | 143 | 3 | EFO_0022256 | |
| Disease | Hypoxanthine measurement | 1.76e-03 | 13 | 143 | 2 | EFO_0021604 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.76e-03 | 13 | 143 | 2 | C0751122 | |
| Disease | pipecolate measurement | 1.76e-03 | 13 | 143 | 2 | EFO_0021006 | |
| Disease | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement | 1.76e-03 | 13 | 143 | 2 | EFO_0800413 | |
| Disease | cognitive inhibition measurement | 1.85e-03 | 50 | 143 | 3 | EFO_0007969 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 1.96e-03 | 51 | 143 | 3 | EFO_0022242 | |
| Disease | coronary artery disease | NPC1 FNDC3B HIVEP2 THSD7A INPP5D F13A1 SVEP1 MAPK8IP3 SINHCAF CLIC5 NRXN1 PKHD1 CABIN1 PALLD | 2.04e-03 | 1194 | 143 | 14 | EFO_0001645 |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 2.19e-03 | 53 | 143 | 3 | EFO_0022258 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 2.31e-03 | 54 | 143 | 3 | EFO_0022244 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 2.35e-03 | 15 | 143 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | chenodeoxycholate measurement | 2.35e-03 | 15 | 143 | 2 | EFO_0010471 | |
| Disease | Alzheimer disease | 2.59e-03 | 485 | 143 | 8 | MONDO_0004975 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 2.68e-03 | 16 | 143 | 2 | C0393706 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 2.69e-03 | 57 | 143 | 3 | EFO_0022284 | |
| Disease | Myopia | 2.80e-03 | 385 | 143 | 7 | HP_0000545 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 2.83e-03 | 58 | 143 | 3 | EFO_0022338 | |
| Disease | triglycerides to total lipids in small LDL percentage | 2.97e-03 | 59 | 143 | 3 | EFO_0022337 | |
| Disease | white matter microstructure measurement | 3.01e-03 | 390 | 143 | 7 | EFO_0005674 | |
| Disease | SLAM family member 7 measurement | 3.02e-03 | 17 | 143 | 2 | EFO_0008287 | |
| Disease | graft-versus-host disease (is_implicated_in) | 3.02e-03 | 17 | 143 | 2 | DOID:0081267 (is_implicated_in) | |
| Disease | late-onset Alzheimers disease | 3.08e-03 | 292 | 143 | 6 | EFO_1001870 | |
| Disease | total lipids in IDL | 3.12e-03 | 60 | 143 | 3 | EFO_0022161 | |
| Disease | idiopathic dilated cardiomyopathy | 3.12e-03 | 60 | 143 | 3 | EFO_0009094 | |
| Disease | urate measurement, bone density | 3.30e-03 | 619 | 143 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | squamous cell carcinoma (is_implicated_in) | 3.39e-03 | 18 | 143 | 2 | DOID:1749 (is_implicated_in) | |
| Disease | triglycerides to total lipids in IDL percentage | 3.58e-03 | 63 | 143 | 3 | EFO_0022329 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 3.58e-03 | 63 | 143 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 3.58e-03 | 63 | 143 | 3 | EFO_0022239 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 3.74e-03 | 64 | 143 | 3 | EFO_0022253 | |
| Disease | corneal hysteresis | 4.18e-03 | 20 | 143 | 2 | EFO_0010066 | |
| Disease | Dermatitis, Allergic Contact | 4.26e-03 | 67 | 143 | 3 | C0162820 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 4.26e-03 | 67 | 143 | 3 | EFO_0022245 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 4.62e-03 | 69 | 143 | 3 | EFO_0022341 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.62e-03 | 222 | 143 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | anorexia nervosa | 4.81e-03 | 70 | 143 | 3 | MONDO_0005351 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CYAMGETFNETLSVE | 341 | Q86WK6 | |
| SCSEMNGRYSSNEFI | 781 | Q9BQT9 | |
| MTAGDFQEIYSECNT | 291 | Q8N4J0 | |
| ECTESEVMNSLYSGD | 301 | P54646 | |
| CSDQGVTGYDISMST | 766 | Q8N139 | |
| DNDNSTCYMDASTRP | 126 | Q8WU67 | |
| TYMSQVLIQCAGSEE | 481 | Q14155 | |
| DGQEAPSNVYSCSMD | 996 | A2RUS2 | |
| QRSYTMESTLCGCDQ | 1096 | Q9UPW5 | |
| SMEGLYSSTQDQQLC | 106 | Q9NZA1 | |
| RETQTMYKASQESEC | 446 | Q3KR37 | |
| TVSMGIDFCDSTQTA | 946 | O00203 | |
| YESFTNCTEMEANVV | 66 | O60896 | |
| ESDQGAYTCEAMNAR | 471 | P98160 | |
| MSVADSGEYVCRANN | 2686 | P98160 | |
| SVTATRENMAYTVEC | 111 | P22695 | |
| CTRYTPEQDTMTFSD | 276 | P13631 | |
| MGSESTYSECETFTD | 311 | O75154 | |
| CEQTMVNSENTYSSG | 871 | Q14126 | |
| VRLYDETESSFAMTC | 196 | Q8N635 | |
| FMESSEVCTNTYARG | 696 | P32926 | |
| LISNVTDDDSGMYTC | 296 | P43146 | |
| ENGVIYQTFCDMTSG | 61 | Q8WWA0 | |
| TCLLDGMQYFATTES | 1626 | Q14667 | |
| YEETGEFMSSNASEV | 351 | Q86XX4 | |
| EECRMSGEYTNSVSI | 441 | Q86Y46 | |
| QDDYCSGSVMSERVS | 16 | Q9UPT6 | |
| SYQCPQDEMSESGQS | 246 | Q9UPT6 | |
| EDAGRYTCEMSNTLG | 756 | Q96JA1 | |
| MIDDTYQCLTAVAGT | 151 | Q9UBB6 | |
| QLTMADNGTYECSVS | 106 | Q99795 | |
| DNGTYECSVSLMSDL | 111 | Q99795 | |
| YCLFGDTVNTASRME | 996 | Q02846 | |
| VECVQEGVTMETAYS | 816 | Q9Y6X6 | |
| YSCGDQNTLMEESAE | 706 | Q05193 | |
| VYSFNEVRGSNMSCT | 436 | Q5VTL7 | |
| VSTAEVADAASYMCV | 2911 | Q8NDA2 | |
| EGSCSTAGCQEVYVM | 626 | Q8NBH2 | |
| EEYRMSGECQSAVSI | 446 | P19013 | |
| EGYRDVNICNMTTSF | 16 | Q8IY33 | |
| STLYETGGCDMSLVN | 881 | Q96RV3 | |
| NQTCEFYGRSMSEIV | 991 | O75051 | |
| DSGQNGMVTCYTQEE | 371 | Q9Y5G3 | |
| ICQARASVMVYDDTS | 6 | Q9UI08 | |
| CYVDMSTVDADTVTE | 356 | Q49A26 | |
| MNDSTVEQLYETACF | 96 | Q8IY47 | |
| ETIYICGVDEMSTQD | 126 | Q53F19 | |
| CGVDEMSTQDVFSYF | 131 | Q53F19 | |
| ANSDTMACEYLSVEV | 241 | P55160 | |
| TNTTASLGMYECDRE | 101 | Q9UBG0 | |
| EGITTYFSGNCTMED | 166 | Q9NY33 | |
| VDSTPQENSDGMYRC | 396 | P00488 | |
| GTSETILYTCRQDDM | 926 | Q8NG31 | |
| QSSAVMALQEACESY | 86 | Q16695 | |
| EDENNTSTGKYCSMT | 296 | P98164 | |
| SCEREATVLSYDGSM | 711 | Q9ULB1 | |
| SLEEACTMFELSYQN | 746 | Q6ZWE6 | |
| VMADGTTTYVNASVC | 291 | O15442 | |
| VTATRCFDMYEGDNS | 121 | P58499 | |
| VNDTVGTMMSCGYED | 661 | P52790 | |
| TGTNACYMEELRNVA | 686 | P52790 | |
| QTTMEDAGQYTCVVR | 2446 | Q96RW7 | |
| MYNACRDVEAPSSND | 156 | O15118 | |
| CGMRFTTSQTDVYAD | 1346 | O94913 | |
| ANTENCSYESMGESN | 541 | Q8WX93 | |
| MDFTEAYADTCSTVG | 1 | Q9Y575 | |
| IGTYMSVVDDNDCNA | 1136 | Q9P2N4 | |
| TTFMCEYADETATIV | 121 | P60568 | |
| IDTTSEEDSGTYRCM | 286 | Q9BWV1 | |
| ENYDICTEMLQSSTA | 636 | Q9Y6J0 | |
| CIATDDYESESGSMI | 1271 | Q96N67 | |
| SNIFEDVEFCVMSGT | 656 | P49917 | |
| DDVVAMTSDCDIYQT | 101 | Q9P109 | |
| ASESGCEVSEYSVEM | 696 | Q53EP0 | |
| KFSDSERTMEVCYNT | 1016 | Q5TEA3 | |
| VYCNMETGETCISAN | 1326 | P05997 | |
| MGETQSEYSDSSCEN | 501 | P41182 | |
| SSMTMDSEDGYQTCV | 251 | O60759 | |
| LTCSVEDGGNTVMYT | 381 | Q9HBG7 | |
| NISCYETMADASTEL | 231 | P38484 | |
| FAQCSVTYDMESTDN | 156 | O95466 | |
| VTYDMESTDNGASNS | 161 | O95466 | |
| TAVSCESFIMESANG | 161 | Q9BXC0 | |
| ENMEGYSGADITNVC | 411 | O75449 | |
| CECEMGTYLSESQVN | 226 | Q8TB03 | |
| QADSQVTEVCAATYM | 76 | P16410 | |
| IFASNLYESECMNET | 136 | P27707 | |
| GTSMEYCTLAEATQF | 306 | Q9Y3R0 | |
| GCSNSETFMEIDTAQ | 241 | Q92681 | |
| TMDEACQEGNIFVTT | 261 | P23526 | |
| MATTATCTRFTDDYQ | 1 | Q13555 | |
| ESSCGFMVDSDVNAV | 1196 | Q8WYK1 | |
| EFTDYMIRSNESHCS | 491 | Q8N1G2 | |
| LVYNIMSSGEIECSN | 591 | Q96EK7 | |
| SEEIASFECSGYVMS | 341 | Q8N5F7 | |
| NSMVYFGSSQDEEEV | 171 | Q92833 | |
| ASYSVQACSVLTGEM | 706 | Q6ZRI0 | |
| REDTGTYTCMVSEEG | 101 | Q9Y624 | |
| ARITCQGDSMEGSYE | 36 | A0A0A0MS00 | |
| MTCYDSDDANPRSVS | 291 | Q8NEY1 | |
| RVVTDCDYMALNGSQ | 121 | Q8N2A8 | |
| ASMLGCSFYEVSVSE | 171 | Q9BPW5 | |
| DCQTSRDTTMYAVSA | 141 | Q10713 | |
| DMAVLAGNSGETCYS | 261 | Q9NXH9 | |
| TQSTMQTYEEVGDDA | 226 | Q9NX07 | |
| MGSSSLSEDYRQCLE | 1 | Q8IUW3 | |
| DYVAALEGMSSQQCS | 696 | P08582 | |
| CEEGYTEVMSSNSTL | 1536 | Q9UPZ6 | |
| SVCTEVIQSAQGMEY | 1156 | Q9UMZ2 | |
| DGEGCANMLVEYSTS | 171 | Q7L5D6 | |
| VSDMYQLTSLFEECS | 121 | Q9NVX7 | |
| QMRSADEGQTVFYTC | 101 | Q9P1U0 | |
| MSGACTSYVSAEQEV | 1 | Q6UWV7 | |
| VCQSYGSTSDIMTSD | 686 | Q92835 | |
| NYCDGRETSETTAML | 116 | Q96JW4 | |
| ICFQGSEQTAMIDSS | 301 | O15457 | |
| LIYNSSCNITMETEA | 1876 | P08F94 | |
| TDDFSYGMHRVETSC | 121 | Q8IXL7 | |
| GYTMDTDTDTFTCQK | 3151 | Q4LDE5 | |
| TEEEMYSLTETFQRC | 196 | Q9UPV7 | |
| THMYDNAAEACSTTE | 951 | Q9NRY4 | |
| REMVYDCTSSSFDGI | 46 | P63272 | |
| ARCYGFVTMSTAEEA | 446 | Q15424 | |
| EMAQSFSDYSVGSES | 11 | Q9UPX8 | |
| NVDTCTVYADGQAFM | 1526 | Q9UPX8 | |
| SLSQECTLDQTVYAM | 1051 | Q09428 | |
| CSGTIYAEEEGQETM | 61 | Q6UXG3 | |
| NILYFSETTGSMCSE | 26 | O14603 | |
| CYSNQSDDGSDTEMA | 136 | Q9NP50 | |
| CYRSSMTAEQVLNAE | 956 | Q9BXU1 | |
| MQTSQTCEGLYDLSN | 421 | Q32MQ0 | |
| SYSQEGCSDRAQEMA | 411 | A0A0J9YY54 | |
| VTATEGQNVEMSCAF | 36 | Q8TAG5 | |
| SERQCVETVVNMGYS | 391 | Q9NZ09 | |
| CGDSAETASTRFEMF | 411 | O95497 | |
| FAADTGMNRSQSEYC | 1931 | Q8IZQ1 | |
| DSGMTEVERTYSANC | 36 | Q496A3 | |
| GYSQCMETEVIESLG | 116 | Q08AE8 | |
| CVEVDSETEAVYGMT | 21 | Q07699 | |
| CTSESMDYGTNLSTD | 491 | O94804 | |
| CINYTTGEMFDVSVV | 1366 | Q99250 | |
| QGDVASMSCTYSVSR | 36 | A0A075B6U4 | |
| YTCVGTNMVGERDSD | 201 | Q9HCK4 | |
| SSRDSCNDSMQSYDL | 231 | O14795 | |
| SLADSVQTMSCYADV | 2006 | P27708 | |
| YDQATDTIMCVTESI | 801 | Q9Y4G6 | |
| LSIQEGENATMNCSY | 31 | A0A0B4J275 | |
| DESFGVVESDMSYNQ | 256 | H3BQB6 | |
| TGTSETEMSAICQEY | 621 | Q8NEE8 | |
| PSDSCEDTQMTEYQR | 1986 | P31629 | |
| SMDSYEGQEVNITCS | 26 | A0A0B4J268 | |
| TESSEYSCVMDGQTM | 641 | Q9H091 | |
| SSVSYSNMIEPDQCF | 1171 | O60293 | |
| TGMTCQARTSYTEDE | 306 | P48549 | |
| RSSSMADGDNSYCLE | 1641 | Q9ULV0 |